REG - Tate & Lyle PLC - Listing and Trading Application

Tate & LyleAnnouncement

29/04/2022 15:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220429:nRSc9302Ja&default-theme=true

RNS Number : 9302J  Tate & Lyle PLC  29 April 2022

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR
FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE
RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

 

FOR IMMEDIATE RELEASE

 

29 April 2022

Tate & Lyle PLC

("Tate & Lyle")

 

Listing and Trading Application

Further to the circular to shareholders published on 7 April 2022 (the
"Circular") and the announcement published on 26 April 2022, in connection
with the Special Dividend and associated Share Consolidation, Tate & Lyle
announces that application has been made to the Financial Conduct Authority
for a total of 401,603,808 ordinary shares of 29 1/6 pence each (the "New
Ordinary Shares") to be admitted to the premium segment of the Official List
and for the New Ordinary Shares to be admitted to trading on the London Stock
Exchange's main market for listed securities. Although the New Ordinary
Shares will have a different nominal value (being 29 1/6 pence each) to the
Existing Ordinary Shares, they will be traded on the London Stock Exchange in
the same way as the Existing Ordinary Shares and will carry the same rights
under the Articles to the Existing Ordinary Shares.

It is expected that dealings in the New Ordinary Shares will commence at 8.00
a.m. on 3 May 2022.

The ISIN for the New Ordinary Shares is GB00BP92CJ43.

Capitalised terms used but not otherwise defined in this announcement have the
same meaning given to them in the Circular.

For more information contact:

 

For Tate & Lyle PLC

 

Investors and analysts

Christopher Marsh, VP Investor Relations

Tel: Mobile: +44 (0) 7796 192 688

 

Media

Nick Hasell, FTI Consulting

Tel: Mobile: +44 (0) 7825 523 383

 

Information on Tate & Lyle

 

Tate & Lyle is a leading global provider of food and beverage ingredients
and solutions. Supported by our 160-year history of ingredient innovation, we
partner with customers to provide consumers with healthier and tastier choices
when they eat and drink. We are proud that millions of people around the world
consume products containing our ingredients every day.

 

Through our expertise in sweetening, mouthfeel and fibre fortification, we
develop solutions which reduce sugar, calories and fat, add fibre, and provide
texture and stability in categories including beverages, dairy, bakery, soups,
sauces and dressings.

 

We have more than 3,000 employees working in around 60 locations across 30
countries. Tate & Lyle's purpose is Transforming Lives Through the Science
of Food and through our purpose we believe we can successfully grow our
business and have a positive impact on society. We live our purpose in three
ways, by supporting healthy living, building thriving communities and caring
for our planet.

 

Tate & Lyle is listed on the London Stock Exchange under the symbol
TATE.L. American Depositary Receipts trade under TATYY. In the year ended 31
March 2021, Tate & Lyle's revenue from continuing operations totaled £1.2
billion.  For more information, please visit http://www.tateandlyle.com or
follow Tate & Lyle on Twitter or LinkedIn.

 

Tate & Lyle's LEI number is: 2138008K14474WPKZ244

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCBSGDSIGDDGDC